News & Updates

Show Multimedia Only

HCV cure possible in people who inject drugs despite poor treatment adherence

17 May 2024

People who inject drugs (PWID) with low adherence to sofosbuvir/velpatasvir can still be cured of hepatitis C virus (HCV) infection, suggests a study.

HCV cure possible in people who inject drugs despite poor treatment adherence

17 May 2024

Hepatic inflammation, fibrosis influence mid-term mortality in MASLD

07 May 2024

In patients with metabolic dysfunction-associated steatotic liver disease (MASLD), mid-term mortality increases in the presence of hepatic inflammation and fibrosis, as reported in a study.

Hepatic inflammation, fibrosis influence mid-term mortality in MASLD

07 May 2024

Gluten-free diet may improve liver, metabolic parameters in MASLD

28 Apr 2024

Following an amylase trypsin inhibitors (ATI)-free diet for 6 weeks appears to produce substantial improvements in liver and metabolic, as well as patient-reported outcomes, in people with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a proof-of-concept study.

Gluten-free diet may improve liver, metabolic parameters in MASLD

28 Apr 2024

Third-line rescue therapy averts colectomy for some patients with acute severe ulcerative colitis

27 Apr 2024

Third-line rescue therapy appears to be a promising therapeutic strategy in acute severe ulcerative colitis, with a recent study showing that such an approach helps avoid colectomy in most patients.

Third-line rescue therapy averts colectomy for some patients with acute severe ulcerative colitis

27 Apr 2024

Supplementation with essential amino acid improves liver health in teen girls with PCOS

23 Apr 2024 by

Short-term supplementation with a selective essential amino acid (EAA)-containing product significantly improved liver-related outcomes among adolescent girls with polycystic ovarian syndrome (PCOS) in a recent study.

Supplementation with essential amino acid improves liver health in teen girls with PCOS

23 Apr 2024

Paediatric-onset immune-mediated inflammatory diseases raise mortality risk

22 Apr 2024

People with paediatric-onset immune-mediated inflammatory diseases (pIMID) have a roughly fourfold increased risk of death in adulthood, as suggested in a study.

Paediatric-onset immune-mediated inflammatory diseases raise mortality risk

22 Apr 2024

Panobinostat plus vincristine/irinotecan shows potential in hepatoblastoma

17 Apr 2024

Use of panobinostat in combination with vincristine and irinotecan chemotherapy provides effective tumour response in models developed from patients with high-risk, relapsed, and treatment-refractory hepatoblastoma (HB), according to a study.

Panobinostat plus vincristine/irinotecan shows potential in hepatoblastoma

17 Apr 2024

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

17 Apr 2024

For patients with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) cirrhosis, treatment with glucagon-like peptide-1 receptor agonists helps reduce the risk of hepatic decompensation, portal hypertension, hepatocellular carcinoma, and liver transplantation, according to a study.

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

17 Apr 2024

MMF trumps azathioprine for remission in treatment-naive AIH

16 Apr 2024 by

Treatment with mycophenolate mofetil (MMF) in combination with prednisolone results in better biochemical remission rates at 24 weeks than the use of azathioprine plus prednisolone in patients with treatment-naïve autoimmune hepatitis (AIH), reports a study.

MMF trumps azathioprine for remission in treatment-naive AIH

16 Apr 2024

$Long-term TDF use ups fracture risk in older CHB patients$

Long-term TDF use ups fracture risk in older CHB patients

15 Apr 2024

Use of tenofovir disoproxil fumarate (TDF) for ≥24 months increases the risk of fracture in older patients with chronic hepatitis B (CHB), reports a study.

Long-term TDF use ups fracture risk in older CHB patients

15 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

HCV cure possible in people who inject drugs despite poor treatment adherence

HCV cure possible in people who inject drugs despite poor treatment adherence

Hepatic inflammation, fibrosis influence mid-term mortality in MASLD

Hepatic inflammation, fibrosis influence mid-term mortality in MASLD

Gluten-free diet may improve liver, metabolic parameters in MASLD

Gluten-free diet may improve liver, metabolic parameters in MASLD

Third-line rescue therapy averts colectomy for some patients with acute severe ulcerative colitis

Third-line rescue therapy averts colectomy for some patients with acute severe ulcerative colitis

Supplementation with essential amino acid improves liver health in teen girls with PCOS

Supplementation with essential amino acid improves liver health in teen girls with PCOS

Paediatric-onset immune-mediated inflammatory diseases raise mortality risk

Paediatric-onset immune-mediated inflammatory diseases raise mortality risk

Panobinostat plus vincristine/irinotecan shows potential in hepatoblastoma

Panobinostat plus vincristine/irinotecan shows potential in hepatoblastoma

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

MMF trumps azathioprine for remission in treatment-naive AIH

MMF trumps azathioprine for remission in treatment-naive AIH

Long-term TDF use ups fracture risk in older CHB patients

Long-term TDF use ups fracture risk in older CHB patients